Intravitreal ranibizumab treatment of retinal angiomatous proliferation

Acta Ophthalmologica

Volumn 90, Issue 5, 2012, Pages 487-491

  Kramann, Christina A ^a   Schöpfer, Kilian ^a   Lorenz, Katrin ^a   Zwiener, Isabella ^a   Stoffelns, Bernhard M ^a   Pfeiffer, Norbert ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

age related macular degeneration; intravitreal injection; Lucentis; ranibizumab; retinal angiomatous proliferation

Indexed keywords

RANIBIZUMAB;

ADULT; AGED; ANGIOMA; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FOLLOW UP; HUMAN; MAINTENANCE THERAPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA ANGIOMATOUS PROLIFERATION; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA TUMOR; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANGIOMATOSIS; ANTIBODIES, MONOCLONAL, HUMANIZED; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; RETINAL NEOVASCULARIZATION; RETREATMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84864417320     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.01952.x     Document Type: Article

References (31)

1. Bhavsar AR, Ip MS, &, Glassman AR, (2007): The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol 144: 454-456. (Pubitemid 47336932)
2. Borrillo JL, Sivalingam A, Martidis A, &, Federman JL, (2003): Surgical ablation of retinal angiomatous proliferation. Arch Ophthalmol 121: 558-561. (Pubitemid 36427643)
3. Boscia F, Furino C, Sborgia L, Reibaldi M, &, Sborgia C, (2004): Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 138: 1077-1079. (Pubitemid 40040042)
4. Boscia F, Furino C, Prascina F, Delle Noci N, Sborgia L, &, Sborgia C, (2005): Combined surgical ablation and intravitreal triamcinolone acetonide for retinal angiomatous proliferation. Eur J Ophthalmol 15: 513-516. (Pubitemid 41152977)
5. Bottoni F, Massacesi A, Cigada M, Viola F, Musicco I, &, Staurenghi G, (2005): Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 123: 1644-1650. (Pubitemid 41785096)
6. Bressler NM, (2005): Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease. Arch Ophthalmol 123: 1741-1743. (Pubitemid 41785112)
7. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, &, Schneider S, (2006): Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355: 1432-1444. (Pubitemid 44511558)
8. Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA, &, Yannuzzi LA, (2006): Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 124: 487-492.
9. Freund KB, Ho IV, Barbazetto IA, et al., (2008): Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 28: 201-211. (Pubitemid 351643149)
10. Fung AE, Lalwani GA, Rosenfeld PJ, et al., (2007): An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143: 566-583.
11. Ghazi NG, Knape RM, Kirk TQ, Tiedeman JS, &, Conway BP, (2008): Intravitreal bevacizumab (avastin) treatment of retinal angiomatous proliferation. Retina 28: 689-695. (Pubitemid 351655120)
12. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, &, Guyer DR, (2004): Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351: 2805-2816. (Pubitemid 40051904)
13. Gross NE, Aizman A, Brucker A, Klancnik JM Jr, &, Yannuzzi LA, (2005): Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 25: 713-718. (Pubitemid 41254540)
14. Joeres S, Heussen FM, Treziak T, Bopp S, &, Joussen AM, (2007): Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 245: 1597-1602. (Pubitemid 47491546)
15. Johnson TM, &, Glaser BM, (2006): Focal laser ablation of retinal angiomatous proliferation. Retina 26: 765-772. (Pubitemid 44386098)
16. Lai TY, Chan WM, Liu DT, &, Lam DS, (2007): Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245: 1877-1880. (Pubitemid 350154025)
17. Meyerle CB, Freund KB, Iturralde D, et al., (2007): Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 27: 451-457. (Pubitemid 46624285)
18. van de Moere A, Kak R, Sandhu SS, &, Talks SJ, (2007): Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. Am J Ophthalmol 143: 701-704. (Pubitemid 46452494)
19. Nakata M, Yuzawa M, Kawamura A, &, Shimada H, (2006): Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 141: 968-970.
20. Panagiotidis D, Karagiannis DA, &, Baltatzis S, (2006): Photodynamic therapy in retinal angiomatous proliferation stage I. Eur J Ophthalmol 16: 326-329. (Pubitemid 43874406)
21. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, &, Kim RY, (2006): Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355: 1419-1431. (Pubitemid 44511557)
22. Rouvas AA, Papakostas TD, Vavvas D, Vergados I, Moschos MM, Kotsolis A, &, Ladas ID, (2009): Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation: a prospective study. Retina 29: 536-544.
23. Saito M, Shiragami C, Shiraga F, Nagayama D, &, Iida T, (2008): Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 146: 935-941. e1.
24. Sakimoto S, Gomi F, Sakaguchi H, &, Tano Y, (2005): Recurrent retinal angiomatous proliferation after surgical ablation. Am J Ophthalmol 139: 917-918. (Pubitemid 40614784)
25. Shiragami C, Iida T, Nagayama D, Baba T, &, Shiraga F, (2007): Recurrence after surgical ablation for retinal angiomatous proliferation. Retina 27: 198-203.
26. Silva RM, Cachulo ML, Figueira J, de Abreu JR, &, Cunha-Vaz JG, (2007): Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study. Graefes Arch Clin Exp Ophthalmol 245: 1131-1139. (Pubitemid 47034336)
27. Slakter JS, Yannuzzi LA, Schneider U, et al., (2000): Retinal choroidal anastomoses and occult choroidal neovascularization in age-related macular degeneration. Ophthalmology 107: 742-753. discussion 753-4.
28. Spaide RF, Sorenson J, &, Maranan L, (2003): Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 110: 1517-1525. (Pubitemid 36962483)
29. Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, &, Campochiaro PA, (1998): Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 39: 180-188. (Pubitemid 28040477)
30. Wolf A, Kook D, Kreutzer T, Gandorfer A, Haritoglou C, Kampik A, &, Ulbig M, (2008): [Anti-VEGF treatment for retinal angiomatous proliferation]. Ophthalmologe 105: 845-851.
31. Yannuzzi LA, Negrao S, Iida T, et al., (2001): Retinal angiomatous proliferation in age-related macular degeneration. Retina 21: 416-434. (Pubitemid 32971350)